With the extensive use of dialysis catheters in patients undergoing hemodialysis, superior vena cava (SVC) syndrome has gradually attracted attention in recent years. Chylothorax caused by SVC syndrome is rarely reported. In this paper, we report a case of chylothorax secondary to superior vena cava obstruction (SVCO) in a maintenance hemodialysis patient after multiple dialysis catheter placements. Relieving the SVCO through intravascular intervention could effectively treat chylothorax. In the past fourteen months, no recurrence of symptoms has been observed.
BuetheJYFarrellJMcLoneyED. Interventional management of superior vena cava occlusion-induced chylothorax in a patient with sickle cell disease. J Vasc Interv Radiol2016; 27(11): 1751–1753.
3.
AlkayedKPlautzGGowansK, et al. Chylopericardium and chylothorax: unusual mechanical complications of central venous catheters. Pediatr Int2013; 55(2): e4–e6.
4.
GomesAORibeiroSNevesJ, et al. Uncommon aetiologies of chylothorax: superior vena cava syndrome and thoracic aortic aneurysm. Clin Respir J2015; 9(2): 185–188.
5.
LuksVAljohaneyAAmjadiK. Tunneled pleural catheters in the management of chylothorax from central venous catheter-related superior vena cava obstruction. Respiration2013; 86(1): 67–71.
6.
AgarwalAK. Central vein stenosis. Am J Kidney Dis2013; 61(6): 1001–1015.
7.
BeathardGA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int1992; 42(6): 1390–1397.
8.
ToomaySRectenwaldJVazquezMA. How can the complications of central vein catheters be reduced?: Central venous stenosis in hemodialysis patients. Semin Dial2016; 29(3): 201–203.
9.
AdekileAAdegoroyeATedlaF, et al. Chylothorax and chylopericardial tamponade in a hemodialysis patient with catheter-induced superior vena cava stenosis. Semin Dial2009; 22(5): 576–579.
10.
LevitRDCohenRMKwakA, et al. Asymptomatic central venous stenosis in hemodialysis patients. Radiology2006; 238(3): 1051–1056.
11.
ChangCJKoPJHsuLA, et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis2004; 43(1): 74–84.
12.
RenaudCJFrancoisMNonyA, et al. Comparative outcomes of treated symptomatic versus non-treated asymptomatic high-grade central vein stenoses in the outflow of predominantly dialysis fistulas. Nephrol Dial Transplant2012; 27(4): 1631–1638.
13.
LokCEHuberTSLeeT, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis2020;75(4Suppl 2): S1–S164.
14.
SchmidliJWidmerMKBasileC, et al. Editor’s choice – vascular access: 2018 clinical practice guidelines of the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg2018; 55(6): 757–818.
15.
GwonDIKoGYKimJH, et al. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology2013; 266(3): 979–987
